![Andreas Kluge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Kluge
Vorstandsvorsitzender bei
Therapeia GmbH & Co. Kg
Vermögen: 194 Mio $ am 31.05.2026
Profil
Andreas Kluge founded Therapeia GmbH & Co. Kg in 2007, where he is working as Chief Executive Officer from 2007, ABX-CRO advanced pharmaceutical services in 2002, where he is working as General Manager & Medical Director from 2002, ABX advanced biochemical compounds GmbH in 1996, where he worked as Chief Executive Officer from 1996 to 2002, and Telix Pharmaceuticals Ltd. in 2015, where he worked as Non-Executive Director from 2020 to 2024.
Dr. Kluge received his doctorate degree from Freie Universität Berlin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.02.2026 | 20’675’000 ( 6.09% ) | 194 Mio $ | 31.05.2026 |
Aktive Positionen von Andreas Kluge
| Unternehmen | Position | Beginn |
|---|---|---|
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Vorstandsvorsitzender | 01.01.2007 |
ABX-CRO advanced pharmaceutical services | Gründer | 01.08.2002 |
Ehemalige bekannte Positionen von Andreas Kluge
| Unternehmen | Position | Ende |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Gründer | 17.10.2024 |
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Vorstandsvorsitzender | 01.07.2002 |
Ausbildung von Andreas Kluge
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Manufactures chemicals for nuclear medicine applications | Process Industries |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Provides diagnostic and therapeutic radiopharmaceuticals | Health Technology |
ABX-CRO advanced pharmaceutical services |
